K Mross
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
Steinbild S, Burkholder I, Edler L, Hanauske A, Hochhaus A, Strumberg D, Dittrich C, Gillessen Sommer S, Morant R, Frost A, Mross K, Scheulen M. A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. British journal of cancer 2007; 97:1480-5.
03.12.2007A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
03.12.2007British journal of cancer 2007; 97:1480-5
Steinbild S, Burkholder I, Edler L, Hanauske A-R, Hochhaus A, Strumberg D, Dittrich C, Gillessen Sommer Silke, Morant R, Frost A, Mross K, Scheulen M
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
Lehnert M, Mross K, Schueller J, Thürlimann B, Kroeger N, Kupper H. Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer. British journal of cancer 1998; 77:1155-63.
01.04.1998Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
01.04.1998British journal of cancer 1998; 77:1155-63
Lehnert M, Mross K, Schueller J, Thürlimann Beat, Kroeger N, Kupper H
Dexverapamil to overcome epirubicin resistance in advanced breast cancer
Thürlimann B, Hartlapp J, Gastl G, Schumacher K, Schernhammer E, Schüller J, Mross K, Greiner J, Kröger N, Kupper H. Dexverapamil to overcome epirubicin resistance in advanced breast cancer. Journal of cancer research and clinical oncology 1995; 121 Suppl 3:R3-6.
01.01.1995Dexverapamil to overcome epirubicin resistance in advanced breast cancer
01.01.1995Journal of cancer research and clinical oncology 1995; 121 Suppl 3:R3-6
Thürlimann Beat, Hartlapp J, Gastl G, Schumacher K, Schernhammer E, Schüller J, Mross K, Greiner J, Kröger N, Kupper H